Biosenta Inc.
ZRO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.00% | -199.05% | 16.67% | 0.00% | -42.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00% | -199.05% | 16.67% | 0.00% | -42.86% |
| Cost of Revenue | -20.00% | 0.00% | -83.33% | -83.33% | -83.33% |
| Gross Profit | 33.33% | -199.45% | 118.18% | 117.39% | 113.04% |
| SG&A Expenses | 9.74% | -4.37% | -5.41% | -26.16% | -25.79% |
| Depreciation & Amortization | -22.73% | 5.88% | 58.33% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.48% | -8.19% | -7.81% | -26.22% | -26.33% |
| Operating Income | -8.46% | -28.98% | 7.84% | 26.27% | 26.34% |
| Income Before Tax | -9.38% | 63.06% | 63.50% | 64.81% | 65.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.38% | 63.06% | 63.50% | 64.81% | 65.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.38% | 63.06% | 63.50% | 64.81% | 65.11% |
| EBIT | -8.46% | -28.98% | 7.84% | 26.27% | 26.34% |
| EBITDA | -39.97% | -258.04% | -561.90% | -- | -- |
| EPS Basic | 5.28% | 62.43% | 62.23% | 62.24% | 60.69% |
| Normalized Basic EPS | 5.34% | -13.83% | -11.42% | -15.26% | -29.93% |
| EPS Diluted | 5.28% | 62.43% | 62.23% | 62.24% | 60.69% |
| Normalized Diluted EPS | 5.34% | -13.83% | -11.42% | -15.26% | -29.93% |
| Average Basic Shares Outstanding | 16.10% | 10.94% | 12.15% | 11.74% | 9.69% |
| Average Diluted Shares Outstanding | 16.10% | 10.94% | 12.15% | 11.74% | 9.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |